Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edward Frykman Insider Profile
4 Followers
Edward Frykman, Director at Acacia Research, holds 148.85K shares in Arrowhead Pharmaceuticals (Ticker: ARWR), holds 73.29K shares in Acacia Research (Ticker: ACTG).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-22.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Edward Frykman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Edward Frykman
Edward Frykman's Trading History
Acacia Research
Jan 06, 2015
Director
Uninformative Buy
―
$372.31K
Arrowhead Pharmaceuticals
Jan 03, 2018
Director
Uninformative Buy
―
$3.29M
List of latest transactions for each holding click on a transaction to see Edward Frykman's performance on stock
You May Also Like
Edward Frykman insider profile FAQ
What is the percentage of profitable transactions made by Edward Frykman?
The percentage of profitable transactions made by Edward Frykman is 0%.
What is the average return per transaction made by Edward Frykman?
The average return per transaction made by Edward Frykman is -22.40%.
What stocks does Edward Frykman hold?
Edward Frykman holds: ACTG, ARWR stocks.
What was Edward Frykman’s latest transaction?
Edward Frykman latest transaction was an Uninformative Buy of ―.
What was Edward Frykman's most profitable transaction?
Edward Frykman’s most profitable transaction was an Informative Sell of ACTG stock on December 9, 2010. The return on the trade was -14.60%.
What is Edward Frykman's role in Acacia Research?
Edward Frykman's role in Acacia Research is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.